Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Frontiers Media S.A. 2022-09-01
Ráidu:Frontiers in Aging Neuroscience
Fáttát:
Alzheimer’s disease
nicotinamide riboside
gut microbiome
APP/PS1 transgenic mice
neuroinflammation
aging
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Interneahtta

https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Geahča maid